Bio-techne8-K

Other Events

Sep 14
Bio-techne10-K

Annual Report · ended 2026-06-30 · Rev $1.2B

Aug 24
Bio-techne4

Bohnen Shane transacted shares; Bohnen Shane bought 11,344 shares at $0.00 on 2026-08-17 (+3 more)

Aug 19
Bio-techne4

Kelderman Kim transacted shares; Kelderman Kim bought 57,590 shares at $0.00 on 2026-08-17 (+3 more)

Aug 19
Bio-techne4

Hippel James transacted shares; Hippel James bought 22,438 shares at $0.00 on 2026-08-17 (+3 more)

Aug 19
Bio-techne4

Herr Amy E. transacted shares; Herr Amy E. transacted shares (+3 more)

Aug 19
Bio-techne4

Crouse Steven C. transacted shares; Crouse Steven C. bought 8,702 shares at $0.00 on 2026-08-17 (+3 more)

Aug 19
Bio-techne8-K

Earnings Release; Other Events; Financial Statements

Aug 12
Bio-techne4

Hippel James bought 62,068 shares at $47.60 on 2026-07-29; Hippel James sold 51,024 shares at $72.03 on 2026-07-29 (+3 more)

Aug 1
Bio-techne4

Kelderman Kim bought 35,000 shares at $47.60 on 2026-07-28; Kelderman Kim sold 28,686 shares at $72.07 on 2026-07-28 (+3 more)

Jul 31
Bio-techne4

Bohnen Shane bought 448 shares at $47.60 on 2026-07-23; Bohnen Shane sold 344 shares at $71.77 on 2026-07-23 (+3 more)

Jul 28
Bio-techne8-K

8-K current report

Jun 26
Bio-techne8-K

8-K current report

Jun 25
Bio-techne4

Crouse Steven C. bought 600 shares of Common Stock at $N/A on 2026-06-02; Crouse Steven C. sold 216 shares of Common Stock at $49.77 on 2026-06-02; Crouse Steven C. sold 600 shares of Restricted Stock Units at $N/A on 2026-06-02; Crouse Steven C. transacted N/A shares of Restricted Stock Units at $N/A on N/A; Crouse Steven C. transacted N/A shares of Stock Option (right to buy) at $N/A on N/A

Jun 5
Bio-techne4

Herr Amy E. bought 6,636 shares of Common Stock at $47.60 on 2026-05-08; Herr Amy E. sold 6,636 shares of Common Stock at $48.28 on 2026-05-08; Herr Amy E. transacted N/A shares of Common Stock at $N/A on N/A; Herr Amy E. sold 6,636 shares of Stock Option (Right to Buy) at $N/A on 2026-05-08; Herr Amy E. transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A

May 13
Bio-techne4

Hippel James bought 62,000 shares of Common Stock at $47.60 on 2026-05-05; Hippel James sold 56,955 shares of Common Stock at $56.68 on 2026-05-05; Hippel James sold 62,000 shares of Stock Options (Right to Buy) at $N/A on 2026-05-05; Hippel James transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A; Hippel James transacted N/A shares of Performance Restricted Stock Units at $N/A on N/A

May 8
Bio-techne4

Bohnen Shane bought 8,400 shares of Common Stock at $47.60 on 2026-05-05; Bohnen Shane sold 7,055 shares of Common Stock at $56.68 on 2026-05-05; Bohnen Shane sold 8,400 shares of Stock Option (Right to Buy) at $N/A on 2026-05-05; Bohnen Shane transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Bohnen Shane transacted N/A shares of Restricted Stock Units at $N/A on N/A

May 8
Bio-techne4

Kelderman Kim bought 26,692 shares of Common Stock at $47.60 on 2026-05-05; Kelderman Kim sold 23,951 shares of Common Stock at $56.68 on 2026-05-05; Kelderman Kim sold 26,692 shares of Stock Option (Right to Buy) at $N/A on 2026-05-05; Kelderman Kim transacted N/A shares of Stock Option (Right to Buy) at $N/A on N/A; Kelderman Kim transacted N/A shares of Stock Options (Right to Buy) at $N/A on N/A

May 8
Bio-techne10-Q

BIO-TECHNE Corp filed 10-Q on 2026-05-06

May 7
Bio-techne8-K

8-K current report

May 6